Last reviewed · How we verify
usual long term cardiac medications
At a glance
| Generic name | usual long term cardiac medications |
|---|---|
| Sponsor | Scios, Inc. |
| Modality | Small molecule |
| Phase | Phase 3 |
Approved indications
Common side effects
Key clinical trials
- Aerobic Exercise in Parkinson's Disease (NA)
- Palliative Care Intervention to Improve Health Related Quality of Life for Patients on Long-Term LVAD Support (NA)
- Evaluation of Remote Motivational Interviewing for Disease Management in Heart Failure Patients and Their Carers (NA)
- Towards Testing the Effectiveness of Recovery Community Centers (RCCs) (NA)
- Effectiveness of an AI-Enabled Stratified Management System for Premature Coronary Artery Disease (NA)
- DCB for CAD With Type 2 Diabetes (NA)
- Medicine-induced Cardiac Hemodialysis on COVID-19 (PHASE4)
- Myocardial Infarction Prescription Duration Adherence Study (NA)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |